Femtosecond arcuate corneal incisions combined with a Light Adjustable Lens for correcting astigmatism during lens surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing cataract extraction or refractive lens exchange will receive femtosecond laser–created paired arcuate corneal incisions at the time of implantation of a Light Adjustable Lens (LAL). Postoperative care includes LAL light treatments as indicated and scheduled follow-up visits to measure residual refractive astigmatism, visual acuity, patient satisfaction, and adverse events. The protocol uses automated corneal measurements (Pentacam AXL and IOLMaster 700) for eligibility and planning, and outcomes will be compared with established astigmatism-correction approaches. The study focuses on safety and refractive accuracy when combining modern femtosecond arcuate incisions with the adjustable optics of the LAL.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subject must be aged ≥ 21 years at the time of eligibility visit.
2. Subject must have a vector difference of 0.50 D or less in magnitude of pre-operative anterior corneal astigmatism as measured by the Pentacam AXL and the Zeiss IOLMaster 700 (Carl Zeiss Meditec).
3. Subject must be able and willing to comply with the study examination procedures.
4. Astigmatic treatment must require paired arcs \<45mm in length.
5. Subject must be willing to complete the approved informed consent form.
6. Subject must have elected to undergo lens extraction and Light Adjustable Lens (LAL) implantation.
7. Subject must be willing and able to return for scheduled pre-op and follow-up examinations.
8. Subject must have central 7 mm of clear cornea without vascularization.

Exclusion Criteria:

1. Subject who has undergone previous corneal or intraocular surgery in the eye to be treated.
2. Subject with a history, signs or symptoms of ocular disease or atypical findings that would be contraindicated under standard of care for lens extraction surgery.
3. Subject with neuro-ophthalmic disease.
4. Diabetic or hypertensive subject with clinical evidence of retinal pathology that the investigator believes will significantly affect visual outcomes.
5. Subject with macular degenerative pathology identified at the preoperative visit that the investigator believes will significantly affect visual outcomes.
6. Subject with a history of steroid-responsive rise in intraocular pressure (IOP), preoperative IOP \>25 mmHg, or uncontrolled glaucoma in either eye.
7. Subject with known lens/zonular instability.
8. Subject who cannot achieve dilated pupillary diameter \> 6 mm.
9. Subject with abnormal corneal topography, including evidence of forme fruste keratoconus, keratoconus or pellucid marginal degeneration.
10. Subject with posterior segment disease or degeneration.
11. Subject with corneal disease or pathology that precludes an adequate view for imaging or transmission of laser wavelength of light.
12. Subject with known sensitivity to planned perioperative standard of care medications.
13. Subject participating in any other ophthalmic drug or device clinical trial during the time of this clinical assessment.
14. Subject with known sensitivity to planned assessment concomitant medications.
15. Subjects with severe dry eye syndrome (DES) or history of ocular inflammation that may impact visual outcomes.
16. Subject with irregular astigmatism in the eye to be treated.

Where it's running

• Center For Sight
  Venice, Florida, United States Recruiting
• Carolina Eyecare Physicians
  Mt. Pleasant, South Carolina, United States Recruiting

Study contacts

• Principal investigator: Priya Mathews, MD — Center For Sight - Clinical Studies
• Study coordinator: Helga P Sandoval
• Email: hps@cepmd.com
• Phone: 8438813937

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia

  This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.

  Recruiting CooperVision International Limited (CVIL) · New York, New York and 2 other locations · NCT07829419

• Seeing clearly in low light after Ray-Tracing guided LASIK

  A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.

  Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790185

• Orthokeratology contact lenses with a 5 mm optic zone diameter

  This study tests Paragon CRT lenses with a 5 mm optic zone in kids and young adults to see how well they fit, how well they vision, and how comfortable they are at night.

  Recruiting at 2 sites CooperVision International Limited (CVIL) · Pleasanton, California and 2 other locations · NCT07751172

• Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation

  This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.

  Recruiting Eye Clinic Medic Zuljan Jukic · Split, Splitsko-dalmatinska County · NCT07722247

• SMILE in one eye vs Ray tracing-guided LASIK in the fellow eye

  This study tests two laser vision correction methods—SMILE in one eye and ray-tracing guided LASIK in the other eye—to see which provides better vision and quality of life for adults with myopia and astigmatism.

  Recruiting Phase 4 Stanford University · Palo Alto, California · NCT07721714

• Nomogram for Astigmatism Correction of KLEx

  This study tests whether using a nomogram can improve outcomes after astigmatism correction in adults who meet certain eye health criteria.

  Recruiting Tianjin Eye Hospital · Tianjin, Tianjin Municipality · NCT07605221

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.